产品封面图

Merimepodib,198821-22-6

收藏
  • ¥491 - 4963
  • MedChemExpress(MCE)已认证
  • 美国
  • HY-13986
  • 2025年12月05日
    avatar
    品牌商
    14钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 保存条件

      Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.

    • 英文名

      VX-497; MMPD

    • 库存

      货期:1-2天

    • 供应商

      MedChemExpress LLC

    • CAS号

      198821-22-6

    • 规格

      10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg/50 mg

    规格:10 mM * 1 mL产品价格:¥1125.0
    规格:1 mg产品价格:¥491.0
    规格:5 mg产品价格:¥1130.0
    规格:10 mg产品价格:¥1863.0
    规格:25 mg产品价格:¥3475.0
    规格:50 mg产品价格:¥4963.0

    MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。

    Merimepodib

    CAS No. : 198821-22-6

    MCE 国际站:Merimepodib

    产品活性:Merimepodib (VX-497) 是非竞争型,有口服活性的肌苷一磷酸脱氢酶 (IMPDH) 抑制剂,具有广谱抗病毒活性。

    研究领域:Anti-infection

    作用靶点:Flavivirus  |  HBV  |  HCV

    In Vitro: VX-497 has antiproliferative effect on lymphoid and keratinocyte cells. The antiproliferative effect of VX-497 in cells is reversed within 48 h of its removal. VX-497 has intermediate antiviral activity against a second group of viruses, which includes HSV-1, parainfluenza-3 virus, BVDV, VEEV, and dengue virus, with IC50s ranging from 6 to 19 μM. VX-497 is 100-fold more potent, with an IC50 of 380 nM and a corresponding CC50 of 5.2 μM, for a therapeutic index of 14. The antiviral activity of VX-497 in HepG2.2.2.15 cells is reversed threefold by the addition of guanosine.

    In Vivo: Oral administration of VX-497 inhibits the primary IgM antibody response in a dose-dependent manner, with an ED50 value of appr 30-35 mg/kg in mice. Single daily dosing of VX-497 is observed to be as effective as twice-daily dosing in this model of immune activation. GVHD developed in the vehicle-treated allografted F1 mice and treatment with VX-497 improved all manifestations of the disease significantly. The 2.9-fold increase in spleen weight in allografted animals is reduced to a 1.6-fold increase in the VX-497-treated mice. Serum IFN-gamma levels are increased 54-fold in the vehicle group while there is a 7.4-fold increase in VX-497-treated animals.

    相关产品:Covalent Screening Library Plus  |  Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Anti-Infection Compound Library  |  Clinical Compound Library  |  Antiviral Compound Library  |  Drug Repurposing Compound Library  |  Covalent Screening Library  |  Anti-COVID-19 Compound Library  |  Anti-Hepatitis C Virus Compound Library  |  Anti-Pulmonary Fibrosis Compound Library  |  Heterocyclic Compound Library  |  Doxorubicin hydrochloride  |  Nicotinamide  |  Resiquimod  |  Emricasan  |  Honokiol  |  Ribavirin  |  Deferiprone  |  Ivermectin  |  U18666A  |  AG-1478  |  Punicalagin  |  Artemisinin  |  EIDD-1931  |  Asunaprevir  |  Myriocin  |  Mycophenolic acid  |  OSS_128167  |  ML-SA1  |  Grazoprevir  |  Lamivudine  |  Simeprevir  |  NIM811  |  Sofosbuvir  |  Estradiol benzoate  |  RO8191  |  Tenofovir  |  Vesatolimod  |  Quinine  |  GS-443902 trisodium

    热门产品线:重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

    Trending products:Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

    类药多样性化合物库
    顾客使用MCE产品发表的科研文献
    一站式药筛新体验
    MCE 您身边的生物活性分子大师 | 抑制剂、激动剂、化合物库
    重组蛋白 | 高纯度、高稳定性
    磁珠
    MCE Hotline: 4008203792 | 中国现货 - 全球文献引用 - 高纯度高品质 - 全方位技术支持

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1103
    爱必信(上海)生物科技有限公司
    2025年05月23日询价
    ¥3904
    深圳欣博盛生物科技有限公司
    2025年07月15日询价
    询价
    艾美捷科技有限公司
    2025年07月15日询价
    ¥195
    上海三抒生物科技有限公司
    2025年10月31日询价
    Merimepodib,198821-22-6
    ¥491 - 4963